Creative Biolabs is offering the most comprehensive services for antibody development projects. With strict regulation and effective execution, we are dedicated to providing the most valuable solutions to complete your projects.
HighlightsCreative Biolabs is offering the most comprehensive services for antibody development projects. With strict regulation and effective execution, we are dedicated to providing the most valuable solutions to complete your projects.
HighlightsCreative Biolabs is offering the most comprehensive services for antibody development projects. With strict regulation and effective execution, we are dedicated to providing the most valuable solutions to complete your projects.
HighlightsCreative Biolabs is offering the most comprehensive services for antibody development projects. With strict regulation and effective execution, we are dedicated to providing the most valuable solutions to complete your projects.
HighlightsCreative Biolabs has established a broad range of platforms for developing novel antibodies or equivalents. These cutting-edge technologies enable our scientists to meet your demands from different aspects and tailor the most appropriate solution that contributes to the success of your projects.
HighlightsWith deep understanding in antibody-related realms and extensive project experience, Creative Biolabs offers a variety of references to help you learn more about our capacities and achievements, including infographic, flyer, case study, peer-reviewed publications, and all kinds of knowledge that can assist your projects. You are also welcome to contact us directly for more specific solutions.
HighlightsGet a real taste of Creative Biolabs, one of the most professional custom service providers in the world. We are committed to providing highly customized comprehensive solutions with the best quality to advance your projects.
HighlightsSingle-domain antibodies (sdAbs), also known as nanobodies, are a powerful tool in modern biotechnology, offering advantages in therapeutic, diagnostic, and research applications due to their small size, high stability, and specificity. To support researchers in rapidly accessing high-quality sdAbs, we offer a Premade Yeast Display Single Domain Antibody Library Screening Service. This service is built around our proprietary premade yeast display sdAb library and our expertise in converting phage display libraries into yeast display systems.
With a diverse library, we can screen a wide range of targets, including proteins, peptides, small molecules, and complex systems like cells and viruses. Using advanced yeast display technology and high-throughput tools like flow cytometry and FACS, we efficiently identify antibodies with high specificity and stability. Our optimized selection strategies and detailed reports ensure you get the best results, tailored to your research or therapeutic needs. This turnkey service simplifies antibody discovery for all types of applications.
| Species | Antibody Library ID | Display Technology | Library Format | Library Size |
| VHH (Llama) | LlaVHH-YDP-1 | Yeast Display | Naïve VHH | 1.5×108 |
We offer a comprehensive range of yeast display library screening services tailored to meet various research and therapeutic needs. Our services cover different antibody formats and provide solutions for diverse applications. Whether you're screening for immune antibodies, cell-based targets, or specific epitopes, we have the expertise and tools to support your project. For more information, please visit the service pages linked below:
Premade Yeast Display ScFv Library Screening
Yeast Display Immune Antibody Library Screening
Yeast Display Antibody Library Screening for Cell-based Target
Yeast Display Library Screening for Mutant Epitope Specific Antibody
Yeast Display Library Screening for TCR-Like Antibody
Yeast Display Library Screening for Anti-GPCR Antibody
Yeast Display Library Screening for pH-Dependent Antibody
Our services are tailored to screen an extensive range of targets, including proteins, peptides, small molecules, and complex biological systems such as cells, viruses, and organelles. This versatility ensures solutions for diverse research and therapeutic needs.
Leveraging cutting-edge flow cytometry and fluorescence-activated cell sorting (FACS), we rapidly and efficiently identify high-affinity binders, expediting the discovery process without compromising accuracy.
Proprietary protocols ensure precise isolation of single-domain antibodies with exceptional specificity, stability, and functionality, meeting the unique requirements of each project.
Every screening project comes with comprehensive reports, including enriched clones, binding profiles, and functional analyses, empowering researchers with actionable insights.
With years of experience in yeast display technology, our team consistently delivers high success rates, even for complex and challenging projects.
Our platform integrates the inherent strengths of yeast display with state-of-the-art screening tools, offering superior outcomes across diverse applications.
We provide turnkey solutions, from initial target screening to final clone delivery, allowing researchers to focus on discovery and innovation while we handle the technical workflow.
Thanks to our streamlined processes and technical expertise, we minimize project turnaround times without sacrificing quality, enabling faster progress for your research goals.
Ready to accelerate your antibody discovery process? today to learn how our Premade Yeast Display Single Domain Antibody Library Screening Service can support your research goals. Whether you have questions about your target, our technology, or project timelines, our team of experts is here to help. Let us deliver the solutions you need to drive your innovations forward. Reach out now to discuss your project and get started!
All listed services and products are For Research Use Only. Do Not use in any diagnostic or therapeutic applications.
| USA:
Europe: Germany: |
|
|
Call us at: USA: UK: Germany: |
|
|
Fax:
|
|
| Email: info@creative-biolabs.com |
2338